January 22, 2025 - 09:22

The City of Piedmont is on the lookout for an experienced finance director who embodies a unique blend of technical expertise and interpersonal skills. The ideal candidate will thrive in a dynamic work environment and demonstrate the ability to collaborate effectively within small teams.
This role is crucial for managing the city's financial operations, ensuring fiscal responsibility, and providing strategic guidance to the council. Candidates should possess a strong background in finance, accounting, or a related field, along with a proven track record in financial management and analysis.
In addition to technical proficiency, the city values soft skills such as communication, problem-solving, and adaptability. The finance director will be expected to engage with various stakeholders, including city officials and the community, to foster transparency and trust in the city's financial practices.
Piedmont aims to attract a finance professional who is not only adept at navigating complex financial landscapes but also committed to enhancing the overall financial health of the city.
May 9, 2026 - 22:04
Compass Diversified Q1 Earnings Call HighlightsCompass Diversified, the publicly traded holding company known as CODI, reported its first-quarter 2026 earnings this week, with management framing the period as one of disciplined execution. Chief...
May 9, 2026 - 00:34
Urbana Corporation Has Filed 2026 First Quarter Interim Financial StatementsTORONTO - Urbana Corporation has submitted its unaudited interim financial statements and management discussion for the first quarter of 2026. The filing covers the three-month period ending March...
May 8, 2026 - 11:59
Australia regulator calls for urgent cybersecurity action to counter MythosAustralia`s corporate watchdog has called on the country`s financial industry to take urgent steps to address cybersecurity risks posed by advanced artificial intelligence systems, including a...
May 7, 2026 - 20:22
IN8bio Reports First Quarter 2026 Financial Results and Recent Business HighlightsIN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The...